Medicare Enrolled

Dr. Jharana Shrestha, MD

Rheumatology · Weatherford, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
920 SANTA FE DR, Weatherford, TX 76086
8177597000
In practice since 2006 (19 years)
NPI: 1548228125 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shrestha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shrestha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shrestha

Dr. Jharana Shrestha is a rheumatology in Weatherford, TX, with 19 years in practice. Based on federal Medicare data, Dr. Shrestha performed 4,793 Medicare services across 489 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shrestha received a total of $5,654 from 40 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shrestha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 43% volume in TX$ $5,654 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,793
Medicare services
Top 43% in TX for rheumatology
489
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~252 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)4,020$18$42
Office visit, established patient (30-39 min)464$82$237
Office visit, established patient (20-29 min)87$52$156
Drug injection, under skin or into muscle81$10$66
New patient office visit (45-59 min)39$118$371
Office visit, established patient, complex (40-54 min)33$129$311
Administration of chemotherapy into vein, each additional hour24$21$93
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less23$48$190
Administration of chemotherapy into vein, 1 hour or less22$99$412
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
86.5% medium
13.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,654
Total received (2018-2024)
Avg $808/year across 7 years
Top 43% in TX for rheumatology
40
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,623 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$31 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168
2023
$469
2022
$718
2021
$612
2020
$357
2019
$1,561
2018
$1,769

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,068
AbbVie, Inc.
$518
PFIZER INC.
$361
Novartis Pharmaceuticals Corporation
$348
AbbVie Inc.
$332
AstraZeneca Pharmaceuticals LP
$306
Horizon Therapeutics plc
$298
E.R. Squibb & Sons, L.L.C.
$296
ABBVIE INC.
$291
Radius Health, Inc.
$182
GlaxoSmithKline, LLC.
$182
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
Celgene Corporation
$161
Corcept Therapeutics
$125
Flexion Therapeutics, Inc.
$105
Valeritas, Inc.
$94
Janssen Biotech, Inc.
$93
Amarin Pharma Inc.
$73
Genentech USA, Inc.
$71
GENZYME CORPORATION
$57
Lilly USA, LLC
$57
Janssen Scientific Affairs, LLC
$49
Abbott Laboratories
$41
Insulet Corporation
$37
Eisai Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$32
Aurinia Pharma U.S., Inc.
$31
Horizon Pharma plc
$28
Novo Nordisk Inc
$25
JAZZ PHARMACEUTICALS INC.
$20
Ultragenyx Pharmaceutical Inc.
$20
Biogen, Inc.
$20
Mylan Specialty L.P.
$17
Sunovion Pharmaceuticals Inc.
$16
Sirtex Medical Inc
$16
Antares Pharma, Inc.
$14
Medtronic MiniMed, Inc.
$14
Cranial Technologies, Inc
$13
Companion Medical, Inc.
$13
VistaPharm, Inc.
$11
Top 3 companies account for 34.4% of total payments
Associated products mentioned in payments ›
ADUHELM · Aimovig · Amitiza · BENLYSTA · Belviq · COSENTYX · Doc Band · EMGALITY · EVENITY · Enbrel · FARXIGA · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · Humira · InPen · JARDIANCE · KEVZARA · KRYSTEXXA · Korlym · LUPKYNIS · Lenvima · Minimed 530G · OFEV · ORENCIA · Omnipod · Otezla · Otrexup · Ozempic · Prolia · RAYOS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIR-Spheres Microspheres · SKYRIZI · STELARA · SUNOSI · Saxenda · TALTZ · TREMFYA · TRULICITY · Thyquidity · Tymlos · Utibron · V-GO · VYVANSE · Vascepa · XELJANZ · Yupelri · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $118 per 100 Medicare services performed
Looking for a rheumatology in Weatherford?
Compare rheumatologys in the Weatherford area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
8
Per 100K population
5.1
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shrestha is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shrestha experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Shrestha performed 4,020 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shrestha receive payments from pharmaceutical companies?
Yes. Dr. Shrestha received a total of $5,654 from 40 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shrestha's costs compare to other rheumatologys in Weatherford?
Dr. Shrestha's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shrestha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →